Risk factors for pre‐transplantation bacteremia in adults with end‐stage liver disease: Effects on outcomes of liver transplantation

Abstract

AbstractBackground and aimLimited data are available regarding pre‐liver transplantation (LT) bacteremia in adults with end‐stage liver disease. In this study, we investigated the risk factors independently associated with pre‐LT bacteremia and their effects on clinical outcomes of LT.MethodsThis retrospective study performed between 2010 and 2021 included 1287 LT recipients. The study population was categorized into patients with pre‐LT bacteremia and those without pre‐LT infection. Pre‐LT bacteremia was defined as bacteremia detected within 90 days before LT.ResultsAmong 1287 LT recipients, 92 (7.1%) developed pre‐LT bacteremia. The mean interval between bacteremia and LT was 28.3 ± 19.5 days. Of these 92 patients, seven (7.6%) patients died after LT. Of the 99 microorganisms isolated in this study, gram‐negative bacteria were the most common microbes (72.7%). Bacteremia was mainly attributed to spontaneous bacterial peritonitis. The most common pathogen isolated was Escherichia coli (25.2%), followed by Klebsiella pneumoniae (18.2%), and Staphylococcus aureus (15.1%). Multivariate analysis showed that massive ascites (adjusted odds ratio [OR] 1.67, 95% confidence Interval [CI] 1.048–2.687) and a prolonged international normalized ratio for prothrombin time (adjusted OR 1.13, 95% CI 1.074–1.257) were independent risk factors for pre‐LT bacteremia in patients with end‐stage liver disease. Intensive care unit and in‐hospital stay were significantly longer, and in‐hospital mortality was significantly higher among LT recipients with pre‐LT bacteremia than among those without pre‐LT infection.ConclusionsThis study highlights predictors of pre‐LT bacteremia in patients with end‐stage liver disease. Pre‐LT bacteremia increases the post‐transplantation mortality risk.